These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12007951)

  • 1. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula.
    Nishimura Y; Suzuki M; Nakamatsu K; Kanamori S; Yagyu Y; Shigeoka H
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):134-9. PubMed ID: 12007951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
    Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer.
    Nishimura Y; Koike R; Nakamatsu K; Kanamori S; Suzuki M; Shigeoka H; Shiozaki H
    Jpn J Clin Oncol; 2003 Jul; 33(7):341-5. PubMed ID: 12949060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
    Ohtsu A; Boku N; Muro K; Chin K; Muto M; Yoshida S; Satake M; Ishikura S; Ogino T; Miyata Y; Seki S; Kaneko K; Nakamura A
    J Clin Oncol; 1999 Sep; 17(9):2915-21. PubMed ID: 10561371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Kumekawa Y; Kaneko K; Ito H; Kurahashi T; Konishi K; Katagiri A; Yamamoto T; Kuwahara M; Kubota Y; Muramoto T; Mizutani Y; Imawari M
    J Gastroenterol; 2006 May; 41(5):425-32. PubMed ID: 16799883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
    Yorozu A; Dokiya T; Oki Y
    Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
    Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].
    Lin Q; Gao XS; Qiao XY; Chen K; Wang YD; Zhou ZG
    Ai Zheng; 2008 Oct; 27(10):1077-81. PubMed ID: 18851788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma.
    Yamashita H; Nakagawa K; Tago M; Nakamura N; Shiraishi K; Mafune K; Kaminishi M; Ohtomo K
    Radiat Med; 2006 Jan; 24(1):65-71. PubMed ID: 16715664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
    Caro M; Font A; Comas S; Viciano M; Remon J; Céliz P; Robles J; Musulén E; Sendrós MJ; Mesalles E; Jiménez JA; Boix J; Arellano A; Fernández-Llamazares J
    Clin Transl Oncol; 2016 Nov; 18(11):1106-1113. PubMed ID: 26856597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy of esophageal carcinoma.
    Poplin EA; Khanuja PS; Kraut MJ; Herskovic AM; Lattin PB; Cummings G; Gaspar LE; Kinzie JL; Steiger Z; Vaitkevicius VK
    Cancer; 1994 Aug; 74(4):1217-24. PubMed ID: 8055441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.